trt with tirzepatide CME INDIA on X: "“Tirzepatide Shown to Tackle Hypogonadism” from ENDO 2025: 📰 CME INDIA – Clinical Pearls: in Obesity-Associated Hypogonadism @Rssdi_official @IndiaESI @AskDrShashank @banshisaboo @DrAmbrishMithal @dramitaol @KapoorNitinDr tirzepatide and testosterone together Tirzepatide

53,54 This distinction is conceptually important because it shifts the emphasis from ROS diffusion to self-propagating redox state transitions

The 6-month oral glutathione RCT documented more than a twofold increase in natural killer (NK) cell cytotoxicity in the high-dose group, and liposomal glutathione raised NK cell cytotoxicity by up to 400% and lymphocyte proliferation by up to 60% in a pilot trial

Very convincing data and reassuring data in weight reduction and CV risk factors improvement Overall, less CV events than expected No significant difference in MACE-5 or MACE-3 but this was relatively small trial with only 1949 participants Confirmation of CV safety but larger CV trials will be needed to further explore protection against major cardiovascular event #retatrutide #obesity #CVevents #MACE #weightreduction #diabetes #lipids #bloodpressure #TRIUMP3trial Martin Haluzks Post -3 3 In TRIUMPH-3, both studied doses of retatrutide (9 mg and 12 mg) delivered substantial weight loss in adults with severe obesity and established cardiovascular disease, with or without type 2 diabetes

S.KirkR